Pharmaceuticals

Precision Oncology Market Outlook 2026–2030 driven by targeted cancer therapies

March 24, 2026March 24, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Will The Market Size Of The Precision Oncology Market Evolve From 2026 To 2030?

The precision oncology market has witnessed rapid expansion in recent years. It is anticipated to increase from $106.21 billion in 2025 to $117.67 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 10.8%. The historical growth can be linked to the limited availability of genomic sequencing technologies, a reliance on conventional chemotherapy, a globally increasing cancer prevalence, the early adoption of immunotherapy, and expanding research in molecular oncology.

The precision oncology market is set for substantial growth over the next few years, with projections indicating it will expand to $175.38 billion by 2030, achieving a compound annual growth rate (CAGR) of 10.5%. This anticipated expansion is attributed to several factors, including the ongoing development of next-generation sequencing platforms, the increasing integration of bioinformatics and artificial intelligence into oncology practices, a rising adoption of liquid biopsy and molecular imaging techniques, the continuous expansion of personalized treatment options, and the growth of collaborative research efforts between hospitals and pharmaceutical companies. Major trends identified for the forecast period include the broader availability of targeted cancer therapies based on molecular profiling, a growing embrace of liquid biopsy and other non-invasive diagnostic methods, an increase in biomarker-based testing to inform personalized treatment plans, the rising incorporation of immunotherapy alongside genomic sequencing, and an enhanced focus on tackling rare and difficult-to-treat cancer types.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27395&type=smp

What Key Drivers Are Influencing The Growth Of The Precision Oncology Market?

A heightened understanding and growing adoption of personalized therapies are projected to stimulate the growth of the precision oncology market moving forward. Personalized therapies are medical interventions specifically designed based on an individual’s genetic makeup, biomarkers, and particular disease characteristics, intending to boost effectiveness and lessen side effects. The expansion of these therapies is attributed to breakthroughs in genomic technologies, which allow for the accurate detection of disease-causing mutations, thereby enabling more potent and precise treatments. Precision oncology contributes to the progress of personalized therapies through the use of genomic and molecular profiling to customize cancer treatment according to the unique genetic profile of a patient’s tumor. As an illustration, in February 2023, GOV.UK, a UK-based government department, reported that the Health and Social Care Secretary signed a Memorandum of Understanding with BioNTech SE to further cancer vaccine research in England, with the goal of providing 10,000 personalized therapy doses to UK patients by 2030. Thus, the increasing awareness and transition towards personalized therapies are indeed propelling the expansion of the precision oncology market.

Which Segment Areas Are Covered In The Precision Oncology Market Analysis?

The precision oncology market covered in this report is segmented –

1) By Type: Genomic Sequencing, Immunotherapy

2) By Test Type: Genetic Tests, Biomarker-Based Tests, Therapeutics

3) By Cancer Type: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Skin Cancer, Stomach Cancer, Other Cancers

4) By Technology: Next-Generation Sequencing, Bioinformatics, Molecular Imaging, Liquid Biopsy

5) By End-users: Hospitals, Research Laboratories, Pharmaceutical Companies, Diagnostic Centers

Subsegments:

1) By Genomic Sequencing: Whole Genome Sequencing, Whole Exome Sequencing, Targeted Gene Sequencing

2) By Immunotherapy: Immune Checkpoint Inhibitors, Cancer Vaccines, Adoptive Cell Therapy

What Key Developments And Trends Are Impacting The Precision Oncology Market?

Leading firms within the precision oncology market are concentrating on creating novel methodologies, like the molecular tumor board, to facilitate personalized treatment choices through the integration of genomic data with clinical backgrounds. This board comprises a specialized group of experts who examine and decode intricate genomic and molecular test results to guide precision-focused cancer treatments customized to a patient’s unique tumor features. As an illustration, in December 2024, Aster DM Healthcare Ltd., a UAE-based healthcare provider, launched a precision oncology clinic as one of three personalized cancer care programs aimed at revolutionizing treatment via data-driven, genomic-centric strategies. The clinic offers tailored cancer therapy derived from each patient’s tumor genetic profile, allowing for more accurate and effective treatments while minimizing adverse reactions. This methodology improves treatment results, lessens toxicity, and elevates quality of life by aligning therapies with the distinctive molecular attributes of a patient’s cancer.

Which Global Companies Are Actively Competing In The Precision Oncology Market?

Major companies operating in the precision oncology market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., AstraZeneca plc., Novartis AG, Amgen Inc., Agilent Technologies Inc., Illumina Inc., Qiagen N.V., Exact Sciences Corporation, NeoGenomics Laboratories Inc., Myriad Genetics Inc., Invitae Corporation, Caris Life Sciences, Foundation Medicine Inc., NanoString Technologies Inc., Personalis Inc., Strata Oncology Inc.

Read the full precision oncology market report here:

https://www.thebusinessresearchcompany.com/report/precision-oncology-global-market-report

Which Region Is Expected To Register The Fastest Growth In The Precision Oncology Market?

North America was the largest region in the precision oncology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the precision oncology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Precision Oncology Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=27395&type=smp

Browse Through More Reports Similar to the Global Precision Oncology Market 2026, By The Business Research Company

Precast Concrete Market 2026

https://www.thebusinessresearchcompany.com/report/precast-concrete-market

Boiler Tank And Shipping Container Market Report 2026

https://www.thebusinessresearchcompany.com/report/boiler-tank-and-shipping-container-global-market-report

Drill Pipe Market Report 2026

https://www.thebusinessresearchcompany.com/report/drill-pipe-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795